These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18201587)

  • 1. Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease.
    Monastero R; Camarda R; Camarda C
    Clin Ther; 2007 Dec; 29(12):2706-9. PubMed ID: 18201587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension.
    Pulido T; Sandoval J; Roquet I; Gutiérrez R; Rueda T; Peña H; Santos E; Miranda MT; Lupi E
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():14-8. PubMed ID: 19335742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady state in healthy subjects.
    Chappell J; He J; Knadler MP; Mitchell M; Lee D; Lobo E
    J Clin Pharmacol; 2009 Dec; 49(12):1456-66. PubMed ID: 19793910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
    Stovall R; Brahm NC; Crosby KM
    Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased INR from concomitant use of acenocoumarol and capecitabine].
    Tomlow B; Voll ML; Smorenburg CH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon.
    Becker ML; Franken WP; Karapinar F; Verzijl-Zeegers R; Schalekamp T; van der Hoeven RT
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1461-5. PubMed ID: 26400679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of initial duloxetine dosing strategies in patients with major depressive disorder.
    Whitmyer VG; Dunner DL; Kornstein SG; Meyers AL; Mallinckrodt CH; Wohlreich MM; Gonzales JS; Greist JH
    J Clin Psychiatry; 2007 Dec; 68(12):1921-30. PubMed ID: 18162024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased INR after gefitinib and acenocoumarol co-administration.
    Ribed A; Escudero-Vilaplana V; Gonzalez-Haba E; Sanjurjo M
    Eur Rev Med Pharmacol Sci; 2014; 18(12):1720-2. PubMed ID: 24992614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for interactions between oral anticoagulants and sertraline.
    Niederhofer H; Pycha R; Huber M
    Med Hypotheses; 2006; 67(6):1461. PubMed ID: 16891063
    [No Abstract]   [Full Text] [Related]  

  • 13. Azathioprine and Acenocoumarol Drug Interaction in Patients with Crohn's Disease: A Case Report.
    Ben-Hammamia S; Charfi O; Belhadj A; Bouchrika A; Chebbi F; Lakhoua G; El Aidli S
    Curr Drug Saf; 2023; 18(2):267-269. PubMed ID: 35469571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial flushing associated with duloxetine use.
    Ezzo DC; Patel PN
    Am J Health Syst Pharm; 2007 Mar; 64(5):495-6. PubMed ID: 17322162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A complex interaction between antitubercular treatment and acenocoumarol.
    Das S; Behera SK; Ramakrishnan K; Ganesapandian M; Munuswamy H; Selvarajan S
    Eur J Clin Pharmacol; 2020 Jan; 76(1):133-135. PubMed ID: 31664473
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence.
    Castro-Diaz D; Palma PC; Bouchard C; Haab F; Hampel C; Carone R; Zepeda Contreras S; Rodriguez Ginorio H; Voss S; Yalcin I; Bump RC;
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Aug; 18(8):919-29. PubMed ID: 17160693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement.
    Blasi A; Muñoz G; de Soto I; Mellado R; Taura P; Rios J; Balust J; Beltran J
    Thromb Res; 2015 Sep; 136(3):669-72. PubMed ID: 26232350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine: clinical pharmacokinetics and drug interactions.
    Knadler MP; Lobo E; Chappell J; Bergstrom R
    Clin Pharmacokinet; 2011 May; 50(5):281-94. PubMed ID: 21366359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.